Radiation DosageLethal Dose 50Drug Administration ScheduleAdministration, OralRadiometryTime FactorsDose-Response Relationship, RadiationDose FractionationRadiotherapy DosageDouble-Blind MethodTreatment OutcomeInjections, IntravenousArea Under CurveRadiotherapy Planning, Computer-AssistedHalf-LifeInfusions, IntravenousBody BurdenThermoluminescent DosimetryRats, Sprague-DawleyDrug InteractionsRelative Biological EffectivenessDrug Therapy, CombinationBiological AvailabilityAntineoplastic AgentsNeoplasmsMetered Dose InhalersRadiation MonitoringInjections, SubcutaneousMetabolic Clearance RateRadiation InjuriesDrug EvaluationRadiotherapy, Intensity-ModulatedRats, WistarAntineoplastic Combined Chemotherapy ProtocolsLiverDisease Models, AnimalInjections, IntramuscularPhantoms, ImagingInjections, IntraperitonealDrug CombinationsAdministration, InhalationRadioisotopesBody WeightIodine RadioisotopesOrgans at RiskDose-Response Relationship, ImmunologicDogsRandom AllocationProspective StudiesBlood PressureAntibodies, MonoclonalDrug SynergismWhole-Body CountingMice, Inbred BALB CChromatography, High Pressure LiquidKidneyRecombinant ProteinsDrug TolerancePlacebosAnalgesics, OpioidMonte Carlo MethodCombined Modality TherapyAnalysis of VarianceNeoplasms, Radiation-InducedRats, Inbred StrainsGamma RaysPlant ExtractsCyclophosphamideHeart RateImmunization ScheduleRats, Inbred F344PregnancyFilm DosimetryRetrospective StudiesLungCesium RadioisotopesModels, BiologicalRabbitsFollow-Up StudiesInfusions, ParenteralMorphineLung NeoplasmsNeutropeniaTomography, X-Ray ComputedDoxorubicinNo-Observed-Adverse-Effect LevelCarcinogensClinical Trials as TopicNebulizers and VaporizersNauseaBehavior, AnimalAerosolsPiperidinesBrainKineticsAntineoplastic Agents, PhytogenicAnti-Bacterial AgentsImmunization, SecondaryImmunosuppressive AgentsVomiting